Philadelphia, PALife SciencesCohort: 2019-2020

Prohibix is creating a disease-modifying therapeutic platform targeting tissue degeneration in patients suffering from diseases such as cardiovascular disease, osteoarthritis, and chronic ulcers. Their patented injectable bio-gel technology allows for the local and sustained delivery of high concentrations of tissue protecting compounds to target areas throughout the body.